Farallon Capital Management LLC Agios Pharmaceuticals, Inc. Transaction History

Farallon Capital Management LLC

$22.3 Billion
Q2 2025

A detailed history of Farallon Capital Management LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 5,767,466 shares of AGIO stock, worth $249 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares

5,767,466

Holding current value

$249 Million

% of portfolio

0.86%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$24.53 - $35.75 $1.64 Million - $2.4 Million	67,000 Added 1.18%	5,767,466 $192 Million
Q1 2025 May 15, 2025	BUY	$29.3 - $35.9 $761,800 - $933,400	26,000 Added 0.46%	5,700,466 $167 Million
Q4 2024 Feb 14, 2025	BUY	$32.86 - $61.64 $446,896 - $838,304	13,600 Added 0.24%	5,674,466 $186 Million
Q3 2024 Nov 14, 2024	BUY	$41.19 - $49.72 $262,133 - $316,418	6,364 Added 0.11%	5,660,866 $252 Million
Q2 2024 Aug 14, 2024	BUY	$27.55 - $48.83 $1.76 Million - $3.12 Million	63,900 Added 1.14%	5,654,502 $244 Million
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $30.3 Million - $49.5 Million	1,423,000 Added 34.14%	5,590,602 $163 Million
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $83.2 Million - $102 Million	4,167,602 New	4,167,602 $92.8 Million
Q3 2023 Nov 14, 2023	BUY	$24.36 - $28.18 $67 Million - $77.5 Million	2,750,829 New	2,750,829 $68.1 Million
Q2 2023 Aug 14, 2023	BUY	$21.38 - $29.19 $12.7 Million - $17.4 Million	596,000 Added 28.48%	2,688,829 $76.1 Million
Q1 2023 May 15, 2023	BUY	$21.74 - $30.93 $1.46 Million - $2.07 Million	67,000 Added 3.31%	2,092,829 $48.1 Million
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $13.1 Million - $16.7 Million	529,000 Added 35.34%	2,025,829 $56.9 Million
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $3.2 Million - $5.59 Million	163,817 Added 12.29%	1,496,829 $42.3 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $34.81 $2.04 Million - $2.66 Million	76,434 Added 6.08%	1,333,012 $38.8 Million
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $13 Million - $21.8 Million	437,811 Added 53.47%	1,256,578 $41.3 Million
Q3 2021 Nov 15, 2021	SELL	$41.92 - $58.18 $14.3 Million - $19.9 Million	-341,233 Reduced 29.42%	818,767 $37.8 Million
Q2 2021 Aug 13, 2021	SELL	$52.06 - $61.27 $4.69 Million - $5.51 Million	-90,000 Reduced 7.2%	1,160,000 $63.9 Million
Q1 2021 May 17, 2021	BUY	$44.23 - $57.5 $11.1 Million - $14.4 Million	250,000 Added 25.0%	1,250,000 $64.6 Million
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $2.77 Million - $3.88 Million	-83,429 Reduced 7.7%	1,000,000 $43.3 Million
Q3 2020 Nov 16, 2020	SELL	$33.87 - $55.93 $5.64 Million - $9.32 Million	-166,571 Reduced 13.33%	1,083,429 $37.9 Million
Q4 2019 Feb 13, 2020	BUY	$30.08 - $50.59 $37.6 Million - $63.2 Million	1,250,000 New	1,250,000 $59.7 Million

Others Institutions Holding AGIO

# of Institutions

241

Shares Held

61.8M

Call Options Held

297K

Put Options Held

235K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.37B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account

Farallon Capital Management LLC Agios Pharmaceuticals, Inc. Transaction History